The Patent Finder

Aska Pharmaceutical Co., Ltd.

Also on record
Records under this name other than the patents Aska Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 21 patents it holds.

Back to Aska Pharmaceutical Co., Ltd.

PatentTitleStatus Expires Confidence
US 8,980,872Agent for Preventing And/Or Treating Functional Gastrointestinal Disorder
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,632,065Microneedle device containing recombinant follicle stimulating hormone
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,829,000Substituted Imidazo[1,5-a]quinoxalines as Phosphodiesterase 9 Inhibitors
Lapsed on the fee record
Ended Sep 9, 2026 · High confidence
Lapsed on the fee recordEnded Sep 9, 2026High confidence
US 8,748,437Crystal of 2-(3,4 dichlorobenzyl)-5-methyl-4-oxo-3,4-dihydrothien[2,3-D]pyrimidine-6-carboxylic acid
Lapsed on the fee record
Ended Jun 10, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 10, 2026From the USPTO record
US 8,377,944Thienopyrimidine derivatives
Lapsed on the fee record
Ended Feb 19, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 19, 2025From the USPTO record
US 7,339,022Peptide Fragment of LYVE-1 and Antibody Against the Same
Formerly held
Term ended
Term ended Mar 11, 2024 · High confidence
Term endedTerm ended Mar 11, 2024High confidence
US 7,939,536Pyrimidinylisoxazole derivatives
Lapsed on the fee record
Ended May 10, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 10, 2023From the USPTO record
US 7,799,775Pyrimidine derivatives
Lapsed on the fee record
Ended Sep 21, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 21, 2022From the USPTO record
US 7,098,027Method for remyelinating a demyelinized lesion due to injury in the brain or spinal cord
Formerly held
Term ended
Term ended Nov 24, 2021 · From the USPTO record
Term endedTerm ended Nov 24, 2021From the USPTO record
US 7,608,716Pyrazolonaphthyridine derivative
Lapsed on the fee record
Ended Oct 27, 2021 · From the USPTO record
Lapsed on the fee recordEnded Oct 27, 2021From the USPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited